AL3-27310-45949
2 vaccinations
4 coded responses
23 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 577 / SD
- Registered
- 2022-02-25
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-02-25
Registered in v-safe
-
2022-02-25
Dose 1 — Moderna
-
2022-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-02-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-02-28
- 2022-03-01
- 2022-03-02
- 2022-03-03
- 2022-03-04
- 2022-03-11
- 2022-03-18
-
2022-03-25
Dose 2 — Moderna
-
2022-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-03-27
- 2022-03-28
- 2022-03-29
- 2022-03-31
- 2022-04-01
-
2022-04-08
Survey response — day 14, dose 2MedDRA: Lacrimation increased, Nasal congestion, Rhinorrhoea, Throat irritation — Feeling: GoodFree text: stuffy and runny nose, scratchy throat, watery eyes.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-15
- 2022-04-22
- 2022-04-29
-
2022-05-06
Survey response — day 42, dose 2MedDRA: Ageusia, Anosmia, Nasal congestion, Paranasal sinus discomfort, Rhinorrhoea, Throat irritation — Feeling: FairFree text: Stuffy nose and runny nose, sinus pressure, scratchy throat, temporary loss of smell and tasteMedDRA releases: 2024-11 · check-in free text available
- 2022-06-24
-
2022-09-25
Survey response — 6 months, dose 2MedDRA: Chest pain, Cough, Headache, Rhinorrhoea — Feeling: FairFree text: Runny nose cough headache chest painMedDRA releases: 2024-11 · check-in free text available
-
2023-03-27
Survey response — 12 months, dose 2MedDRA: Ageusia, Oropharyngeal pain — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-02-25 | Moderna | No |
| 2 | 2022-03-25 | Moderna | No |
Free text
Release 11 — day 14, dose 2
Symptoms: stuffy and runny nose, scratchy throat, watery eyes.
Release 11 — day 42, dose 2
Symptoms: Stuffy nose and runny nose, sinus pressure, scratchy throat, temporary loss of smell and taste
Release 12 — 6 months, dose 2
Symptoms: Runny nose cough headache chest pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release